Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $18,220 | 1,130 | 93.6% |
| Travel and Lodging | $969.35 | 5 | 5.0% |
| Education | $267.39 | 16 | 1.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,390 | 170 | $0 (2024) |
| Medtronic MiniMed, Inc. | $1,786 | 25 | $0 (2020) |
| AstraZeneca Pharmaceuticals LP | $1,538 | 48 | $0 (2024) |
| GlaxoSmithKline, LLC. | $1,387 | 114 | $0 (2024) |
| PFIZER INC. | $1,371 | 107 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $1,199 | 98 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $1,012 | 62 | $0 (2024) |
| ABBVIE INC. | $908.03 | 65 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $581.22 | 31 | $0 (2023) |
| Amgen Inc. | $580.77 | 44 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,078 | 61 | Novo Nordisk Inc ($233.65) |
| 2023 | $1,687 | 106 | Novo Nordisk Inc ($233.40) |
| 2022 | $1,709 | 118 | Novo Nordisk Inc ($401.78) |
| 2021 | $2,240 | 149 | Novo Nordisk Inc ($340.52) |
| 2020 | $3,448 | 140 | Medtronic MiniMed, Inc. ($1,763) |
| 2019 | $2,520 | 156 | Janssen Pharmaceuticals, Inc ($348.42) |
| 2018 | $2,859 | 187 | AstraZeneca Pharmaceuticals LP ($429.73) |
| 2017 | $3,914 | 234 | SANOFI-AVENTIS U.S. LLC ($356.10) |
All Payment Transactions
1,151 individual payment records from CMS Open Payments — Page 1 of 47
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/24/2024 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $76.95 | General |
| Category: Endocrinology | ||||||
| 12/17/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: UROLOGY | ||||||
| 12/16/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.21 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 12/02/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Cardio-renal | ||||||
| 11/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 11/18/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Obesity | ||||||
| 11/18/2024 | Sumitomo Pharma America, Inc. | GEMTESA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: UROLOGY | ||||||
| 11/14/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $15.86 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.34 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: Cardio-renal | ||||||
| 11/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: NEUROSCIENCE | ||||||
| 10/21/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 10/17/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $19.31 | General |
| Category: Respiratory | ||||||
| 10/10/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.07 | General |
| Category: RESPIRATORY | ||||||
| 09/30/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $11.85 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.56 | General |
| Category: Diabetes | ||||||
| 09/10/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $7.98 | General |
| Category: NEUROSCIENCE | ||||||
| 09/09/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $17.32 | General |
| Category: NEUROSCIENCE | ||||||
| 09/05/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
| 08/30/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $22.49 | General |
| Category: GASTROENTEROLOGY | ||||||
| 08/29/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $15.62 | General |
| Category: Diabetes | ||||||
| 08/22/2024 | Mylan Specialty L.P. | YUPELRI (Drug) | Food and Beverage | In-kind items and services | $32.03 | General |
| Category: Anticholinergics, Inhaled | ||||||
| 08/20/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $16.17 | General |
| Category: VACCINE | ||||||
| 08/16/2024 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 08/15/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $16.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 49 | 2,552 | 4,799 | $394,761 | $148,943 |
| 2022 | 44 | 2,112 | 4,237 | $316,265 | $107,911 |
| 2021 | 41 | 2,173 | 4,571 | $320,645 | $108,447 |
| 2020 | 41 | 2,033 | 4,289 | $279,598 | $78,801 |
All Medicare Procedures & Services
175 procedure records from CMS Medicare Utilization — Page 1 of 7
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 187 | 418 | $83,600 | $32,982 | 39.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 195 | 511 | $71,540 | $29,509 | 41.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 115 | 115 | $18,400 | $14,037 | 76.3% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 87 | 291 | $29,100 | $13,108 | 45.0% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2023 | 30 | 30 | $10,500 | $8,184 | 77.9% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 60 | 189 | $17,010 | $6,525 | 38.4% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 24 | 29 | $7,975 | $3,567 | 44.7% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 184 | 354 | $17,700 | $3,555 | 20.1% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 196 | 459 | $6,240 | $3,520 | 56.4% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 42 | 42 | $3,350 | $3,177 | 94.8% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 143 | 248 | $13,888 | $3,153 | 22.7% |
| 77067 | Screening mammography | Office | 2023 | 35 | 35 | $12,075 | $2,892 | 24.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 17 | 18 | $11,700 | $2,030 | 17.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 78 | 127 | $8,636 | $2,025 | 23.4% |
| 99487 | Complex chronic care management services for two or more chronic conditions, first 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 19 | $4,465 | $1,891 | 42.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 65 | 66 | $2,310 | $1,877 | 81.3% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 130 | 213 | $7,242 | $1,585 | 21.9% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 40 | 47 | $5,170 | $1,527 | 29.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 72 | 147 | $5,145 | $1,271 | 24.7% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 64 | 119 | $5,593 | $1,096 | 19.6% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 53 | 70 | $5,250 | $1,014 | 19.3% |
| 99489 | Complex chronic care management services for two or more chronic conditions, each additional 60 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 17 | 19 | $2,185 | $1,002 | 45.8% |
| 93880 | Ultrasound of both sides of head and neck blood flow | Office | 2023 | 11 | 11 | $5,665 | $928.37 | 16.4% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 32 | 32 | $1,120 | $881.64 | 78.7% |
| 90674 | Influenza vaccine, quadrivalent derived from cell cultures, preservative and antibiotic free | Office | 2023 | 24 | 24 | $960.00 | $800.04 | 83.3% |
About Dr. Michael Hood, MD
Dr. Michael Hood, MD is a Family Medicine healthcare provider based in Newport, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/08/2005. The National Provider Identifier (NPI) number assigned to this provider is 1053396432.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Hood, MD has received a total of $19,457 in payments from pharmaceutical and medical device companies, with $1,078 received in 2024. These payments were reported across 1,151 transactions from 65 companies. The most common payment nature is "Food and Beverage" ($18,220).
As a Medicare-enrolled provider, Hood has provided services to 8,870 Medicare beneficiaries, totaling 17,896 services with total Medicare billing of $444,103. Data is available for 4 years (2020–2023), covering 175 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Newport, TN
- Active Since 12/08/2005
- Last Updated 02/07/2024
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1053396432
Products in Payments
- Minimed 670G System (Device) $1,689
- Ozempic (Drug) $1,100
- JARDIANCE (Drug) $757.89
- TRELEGY ELLIPTA (Drug) $748.84
- FARXIGA (Drug) $742.30
- XARELTO (Drug) $702.00
- ELIQUIS (Drug) $573.90
- ENTRESTO (Drug) $452.58
- Vascepa (Drug) $420.32
- BEVESPI AEROSPHERE (Drug) $373.38
- Rybelsus (Drug) $362.94
- VRAYLAR (Drug) $347.50
- Victoza (Drug) $325.78
- UBRELVY (Drug) $317.60
- LYRICA (Drug) $310.75
- INVOKANA (Drug) $309.92
- CHANTIX (Drug) $300.19
- GEMTESA (Drug) $293.10
- ANORO (Drug) $285.19
- Aimovig (Biological) $236.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Newport
Albert Knouse, Md, MD
Family Medicine — Payments: $102,367
Dr. Clayton Kersting, M.d, M.D
Family Medicine — Payments: $35,414
Catherine Spiker, D.o, D.O
Family Medicine — Payments: $22,819
Rajkamal Harricharan Singh
Family Medicine — Payments: $21,552
Karl Sitterly, M.d, M.D
Family Medicine — Payments: $16,066
Dr. David Kickliter, Md, MD
Family Medicine — Payments: $12,702